Health Canada
Symbol of the Government of Canada
Health Concerns

Report on the Review of Sales Transactions for Oxycodone-based Products in Atlantic Canada (Retail Pharmacies only)

List of Tables

SECTION 4

Table 1: Summary table of the number of practitioners, physicians and prescribers (regional and provincial)

Table 2: Summary table of the number of prescribers for General Practice and Family Medicine, and their respective volume of transactions generated

SECTION 5

Table 3: Summary table of findings for Atlantic Canada

SECTION 7

Table 4: Oxycodone-based products sorted by volume of transactions, Atlantic Canada

Table 5: Oxycodone-based products sorted by volume of transactions, New Brunswick

Table 6: Oxycodone-based products sorted by volume of transactions, Nova Scotia

Table 7: Oxycodone-based products sorted by volume of transactions, Newfoundland and Labrador

Table 8: Oxycodone-based products sorted by volume of transactions, Prince Edward Island

Table 9: Volume of transactions of products by prime medical specialty, Atlantic Canada

Table 10: Volume of transactions of products by prime medical specialty, New Brunswick

Table 11: Volume of transactions of products by prime medical specialty, Nova Scotia

Table 12: Volume of transactions of products by prime medical specialty, Newfoundland and Labrador

Table 13: Volume of transactions of products by prime medical specialty, Prince Edward Island